Table 3:
Definition | Type | |
---|---|---|
Primary Outcome | ||
Fidelity in depression screening | Probability that each patient eligible for depression screening completes depression screening. | Binary |
Fidelity in depression treatment initiation | Probability that each patient eligible for depression treatment actually starts treatment within 30 days of identification.* | Binary |
Fidelity in follow-up depression treatment monitoring and adjustment | Probability at each follow-up appointment in the first three months of depression treatment that the clinical treatment decision follows the depression treatment guidelines. | Binary |
Secondary Outcomes | ||
Probability that each patient achieves depression remission at 3 months. | Depression remission is defined as a Patient Health Questionnaire-9 score <5 at 3 months | Binary |
Probability that each NCD patient’s NCD is well controlled at 3 months.** | Well-controlled NCD will be defined for hypertension patients as systolic blood pressure <140 mmHg AND diastolic blood pressure <90 mmHg, and for diabetes patients as fasting blood glucose <130 mg/dl, following the Malawi Clinical Guidelines for the Management of NCDs | Binary |
Eligibility for depression treatment is defined as having a PHQ-9 total score of 5 or above and having a final determination from the treating clinician that the patient is appropriate for depression treatment.
Hypertension is measured by research assistants at each study visit while fasting blood glucose is measured as part of routine clinical care and will be abstracted.